4//SEC Filing
Lurker Nancy 4
Accession 0001562180-25-005390
CIK 0001314102other
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 4:06 PM ET
Size
8.4 KB
Accession
0001562180-25-005390
Insider Transaction Report
Form 4
Lurker Nancy
Director
Transactions
- Exercise/Conversion
Common Stock
2025-07-10+11,111→ 216,547 total - Exercise/Conversion
Restricted Stock Units
2025-07-10−11,111→ 11,112 totalExercise: $0.00→ Common Stock (11,111 underlying)
Holdings
- 126,889(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F2]The restricted stock units vests in three ratable annual installments beginning July 10, 2024.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001450485
Filing Metadata
- Form type
- 4
- Filed
- Jul 10, 8:00 PM ET
- Accepted
- Jul 11, 4:06 PM ET
- Size
- 8.4 KB